Competitive strategies adopted by pharmaceutical firms in Kenya
Abstract
The primary purpose of the study was to study competitive entry strategies adopted by
pharmaceutical companies in Kenya. The target population was managers, head of
departments and top management of pharmaceutical companies in Kenya. The results of
the study were both qualitative and quantitative. Quantitative data collected using a
questionnaire were also analyzed by the use of descriptive statistics using the Statistical
Package for Social Sciences (SPSS) and presented through percentages, means, standard
deviations and frequencies. The information was also represented by use of bar charts,
graphs and pie charts and in prose-form. This was done by tallying up responses,
computing percentages of variations in response as well as describing and interpreting the
data in line with the study objectives through use of SPSS. In assessing competitive
forces and the context within which a company operates, choice of strategy can indeed
seem like a search for a myriad forces pushing and pulling an organization to change and
little by way of established principles to determine what the choice should be. However,
the choice of strategy is fundamental to a company for a number of reasons. The study
recommends further research on governments need to develop effective marketing
systems in the pharmaceutical sector by providing political and social economic changes
in the efforts to give priority for the sector to be effective. There is need for initiatives to
be taken for us to create a sustained and stable competitive strategy and for regional
demand to be able to adjust to foreign technologies needed in the industry. From the
study there is need for competitive advantage as an entry strategy for competitive
strategies on pharmaceutical industry.
Citation
Degree of Master of Business Administration,Publisher
University of Nairobi,